Filing Flows › Bio-Techne (TECH) › Q3 FY26
Bio-Techne (TECH) Q3 FY26 earnings results (third quarter fiscal 2026)
10-Q filed May 6, 2026
Bio-Techne (TECH) reported revenue of $311M for the third quarter fiscal 2026 (Q3 FY26), -2% from a year earlier and +5% from the quarter before. Operating margin was 24.2%, net earnings $51.0M (16.4% of revenue).
Bio-Techne, Q3 FY26: revenue $311M (-2% year over year), operating margin 24.2%, net earnings $51.0M, operating cash flow $86.7M. The chart follows the revenue to costs, profit and cash.
| Q3 FY26 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $311M | +5% | -2% |
| Gross profit | $208M | +9% | -3% |
| Operating profit | $75.5M | +39% | +95% |
| Net earnings | $51.0M | +34% | +126% |
| Operating cash flow | $86.7M | +5% | +111% |
| Free cash flow | $77.6M | +1% | +150% |
What changed
Revenue was $311.4M in Q3 FY26, down 2% year over year and up 5% from the previous quarter. Consumables was the largest line at 83% of revenue. Services lost $5.8M year over year (down 21%), 122% of the total change.
Gross margin was 66.9%, down 1.0 points from Q3 FY25. Operating profit was $75.5M, a 24.2% margin (up 12.0 points year over year). Operating expenses fell 24% while revenue fell 2%. Net earnings were $51.0M, up 126% year over year. The effective tax rate was 28.3%.
Operating cash flow was $86.7M (up 111% year over year), 170% of net earnings. Non-cash charges added back $24.2M of depreciation and amortization and $10.5M of share-based compensation. Capital expenditures of $9.1M left free cash flow of $77.6M.
Questions
What was Bio-Techne's revenue in the third quarter fiscal 2026?
Bio-Techne (TECH) reported revenue of $311M for the third quarter fiscal 2026 (Q3 FY26), -2% from a year earlier and +5% from the quarter before.
Was Bio-Techne profitable in the third quarter fiscal 2026?
Operating profit was $75.5M (24.2% of revenue) and net earnings $51.0M.
Source: Bio-Techne 10-Q on SEC EDGAR.